Special Series eBook: GLP-1 Analysis - Summary - MDSpire
Feature

Special Series eBook: GLP-1 Analysis

  • April 14, 2026

  • 1 min

Share

GLP-1 receptor agonists are transforming diabetes and obesity treatments, prompting analytical scientists to tackle complex challenges in measurement science. This collection highlights significant advancements in GLP-1 research, including innovative mass spectrometry techniques for tracking key drugs like semaglutide and liraglutide. Contributions from experts detail the rapid commercialization of GLP-1 drugs, the resulting innovation in peptide design, and the emerging analytical challenges in impurity profiling and structural characterization. Best practices for GLP-1 peptide analysis, shared by Matthew Lauber of Waters, illustrate the evolution of separation science to support next-generation therapies, emphasizing the critical role of analytical science in developing and regulating GLP-1 treatments during this dynamic period.

Original Source(s)

Related Content